BridgeBio Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $110,565 | $116,633 | $5,882 | $2,732 |
Gross Profit | 106,295 | 116,028 | 3,798 | 2,134 |
EBITDA | -142,704 | -126,183 | -235,048 | -139,655 |
EBIT | -144,021 | -127,467 | -236,415 | -141,193 |
Net Income | -181,903 | -167,422 | -265,050 | -162,040 |
Net Change In Cash | 110,565 | 116,633 | 5,882 | 2,732 |
Free Cash Flow | -85,775 | -199,235 | -198,563 | -182,298 |
Cash | 749,402 | 540,599 | 681,101 | 266,324 |
Basic Shares | 190,517 | 190,145 | 189,437 | 188,510 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $221,902 | $9,303 | $77,648 | $69,716 |
Gross Profit | 218,024 | 6,857 | 74,214 | 66,602 |
EBITDA | -436,829 | -565,468 | -397,443 | -533,833 |
EBIT | -442,904 | -571,962 | -404,214 | -539,676 |
Net Income | -535,762 | -643,202 | -493,964 | -639,297 |
Net Change In Cash | 221,902 | 9,303 | 77,648 | 69,716 |
Cost of Revenue | 20,519 | 37,686 | ||
Free Cash Flow | -521,659 | -529,026 | -425,815 | -546,180 |
Cash | 681,101 | 375,935 | 376,689 | 393,772 |
Basic Shares | 186,076 | 162,791 | 147,473 | 144,356 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.95 |
2025-03-31 | -$0.98 |
2024-12-31 | -$1.37 |
